Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Equity Average (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Equity Average for 15 consecutive years, with $49.4 million as the latest value for Q3 2025.

  • Quarterly Equity Average rose 8.99% to $49.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $49.4 million through Sep 2025, up 8.99% year-over-year, with the annual reading at $47.2 million for FY2024, 10.28% up from the prior year.
  • Equity Average for Q3 2025 was $49.4 million at Xtant Medical Holdings, up from $46.2 million in the prior quarter.
  • The five-year high for Equity Average was $53.0 million in Q4 2023, with the low at $23.9 million in Q1 2021.
  • Average Equity Average over 5 years is $38.5 million, with a median of $33.6 million recorded in 2021.
  • The sharpest move saw Equity Average skyrocketed 5823.51% in 2021, then decreased 16.36% in 2024.
  • Over 5 years, Equity Average stood at $31.8 million in 2021, then rose by 5.39% to $33.5 million in 2022, then surged by 58.39% to $53.0 million in 2023, then fell by 16.36% to $44.3 million in 2024, then increased by 11.5% to $49.4 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $49.4 million, $46.2 million, and $43.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.